$POAI
Predictive Oncology Inc.

2022 Q3 Form 10-Q Financial Statement

#000117184322005622 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $455.8K $371.6K $314.6K
YoY Change 45.32% 6.11% 12.22%
Cost Of Revenue $108.2K $134.1K $109.4K
YoY Change -1.83% -6.16% 11.95%
Gross Profit $347.7K $237.5K $205.1K
YoY Change 70.85% 14.56% 12.36%
Gross Profit Margin 76.27% 63.92% 65.21%
Selling, General & Admin $3.621M $2.623M $2.728M
YoY Change 62.08% 17.2% -19.42%
% of Gross Profit 1041.57% 1104.23% 1329.98%
Research & Development $15.15K $33.39K $68.22K
YoY Change -27.14%
% of Gross Profit 4.36% 14.06% 33.26%
Depreciation & Amortization $227.1K $222.5K $323.6K
YoY Change -4.46% -8.85% 0.5%
% of Gross Profit 65.33% 93.67% 157.76%
Operating Expenses $3.621M $2.623M $2.796M
YoY Change 62.08% 17.2% -19.62%
Operating Profit -$4.131M -$10.53M -$3.414M
YoY Change -24.81% 305.1% -9.63%
Interest Expense $10.22K $95.25K $1.910K
YoY Change 148.06% -408.15% -98.09%
% of Operating Profit
Other Income/Expense, Net $61.05K $38.83K $41.44K
YoY Change 18.73% -29.66% -119.73%
Pretax Income -$4.059M -$10.39M -$3.371M
YoY Change -25.35% 303.71% -13.35%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.059M -$10.39M -$3.371M
YoY Change -25.35% 303.71% -13.32%
Net Earnings / Revenue -890.58% -2796.44% -1071.54%
Basic Earnings Per Share -$0.05 -$0.15 $0.05
Diluted Earnings Per Share -$0.05 -$0.15 -$51.20K
COMMON SHARES
Basic Shares Outstanding 78.38M 68.90M 65.84M
Diluted Shares Outstanding 78.38M 68.90M 65.84M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.39M $28.25M $25.12M
YoY Change -39.21% -37.06% -8.0%
Cash & Equivalents $25.39M $28.25M $25.12M
Short-Term Investments
Other Short-Term Assets $645.2K $763.1K $408.1K
YoY Change 8.39% 215.57% 20.03%
Inventory $493.7K $474.6K $455.7K
Prepaid Expenses
Receivables $324.7K $336.4K $265.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $26.86M $29.82M $26.24M
YoY Change -37.6% -34.65% -6.94%
LONG-TERM ASSETS
Property, Plant & Equipment $2.202M $2.300M $2.336M
YoY Change -42.21% -41.77% -41.25%
Goodwill $0.00 $0.00 $6.858M
YoY Change -100.0% 143.72%
Intangibles $3.702M $3.791M $3.893M
YoY Change 15.71% 16.46% 17.4%
Long-Term Investments
YoY Change
Other Assets $75.62K $75.62K $75.62K
YoY Change -57.78% -39.06% -34.96%
Total Long-Term Assets $6.309M $6.672M $13.81M
YoY Change -22.59% -40.82% 20.63%
TOTAL ASSETS
Total Short-Term Assets $26.86M $29.82M $26.24M
Total Long-Term Assets $6.309M $6.672M $13.81M
Total Assets $33.17M $36.50M $40.06M
YoY Change -35.21% -35.87% 1.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $917.3K $983.7K $1.107M
YoY Change -10.91% 4.43% 7.77%
Accrued Expenses $1.814M $856.7K $695.4K
YoY Change 92.75% -31.8% -45.58%
Deferred Revenue $495.4K $530.8K $182.6K
YoY Change 224.73% 243.9% 18.44%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.468M $2.825M $2.681M
YoY Change 16.15% -12.33% -17.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $99.77K $21.73K $63.10K
YoY Change 222.9% -53.91% -61.31%
Total Long-Term Liabilities $99.77K $21.73K $63.10K
YoY Change 222.9% -53.91% -61.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.468M $2.825M $2.681M
Total Long-Term Liabilities $99.77K $21.73K $63.10K
Total Liabilities $3.573M $2.960M $2.878M
YoY Change 4.94% -22.59% -29.95%
SHAREHOLDERS EQUITY
Retained Earnings -$145.9M -$141.8M -$131.4M
YoY Change 21.26% 23.47% 17.05%
Common Stock $784.1K $781.6K $659.1K
YoY Change 19.78% 19.62% 35.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.59M $33.54M $37.18M
YoY Change
Total Liabilities & Shareholders Equity $33.17M $36.50M $40.06M
YoY Change -35.21% -35.87% 1.02%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.059M -$10.39M -$3.371M
YoY Change -25.35% 303.71% -13.32%
Depreciation, Depletion And Amortization $227.1K $222.5K $323.6K
YoY Change -4.46% -8.85% 0.5%
Cash From Operating Activities -$2.708M -$3.334M -$3.094M
YoY Change -7.82% 51.07% -6.88%
INVESTING ACTIVITIES
Capital Expenditures -$143.7K -$188.2K $45.40K
YoY Change 9.3% -22.81% -88.41%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$143.7K -$188.2K -$80.24K
YoY Change -22.94% -22.81% -79.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.030K 6.656M $86.89K
YoY Change -127.27% -66.76% -99.71%
NET CHANGE
Cash From Operating Activities -2.708M -3.334M -$3.094M
Cash From Investing Activities -143.7K -188.2K -$80.24K
Cash From Financing Activities -4.030K 6.656M $86.89K
Net Change In Cash -2.856M 3.134M -$3.087M
YoY Change -8.16% -82.17% -111.6%
FREE CASH FLOW
Cash From Operating Activities -$2.708M -$3.334M -$3.094M
Capital Expenditures -$143.7K -$188.2K $45.40K
Free Cash Flow -$2.564M -$3.146M -$3.139M
YoY Change -8.63% 60.25% -15.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78155127
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65614597
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36790
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1007393
dei Entity Address Address Line1
EntityAddressAddressLine1
2915 Commers Drive, Suite 900
dei Entity Address City Or Town
EntityAddressCityOrTown
Eagan
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55121
dei City Area Code
CityAreaCode
651
dei Local Phone Number
LocalPhoneNumber
389-4800
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
POAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
240635 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36790
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1007393
dei Entity Address Address Line1
EntityAddressAddressLine1
2915 Commers Drive, Suite 900
dei Entity Address City Or Town
EntityAddressCityOrTown
Eagan
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55121
dei City Area Code
CityAreaCode
651
dei Local Phone Number
LocalPhoneNumber
389-4800
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
POAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78384339
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78384339
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28249452 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28202615 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336397 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
354196 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
474616 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
387684 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
763053 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
513778 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
29823518 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
29458273 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2300327 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2511571 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3790637 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3962118 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
505667 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
814454 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75618 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167065 usd
CY2022Q2 us-gaap Goodwill
Goodwill
0 usd
CY2021Q4 us-gaap Goodwill
Goodwill
6857790 usd
CY2022Q2 us-gaap Assets
Assets
36495767 usd
CY2021Q4 us-gaap Assets
Assets
43771271 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
983672 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1021774 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
856654 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1262641 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
32318 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
129480 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
530797 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
186951 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
421736 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
639662 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2825177 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3240508 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113462 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239664 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21731 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25415 usd
CY2022Q2 us-gaap Liabilities
Liabilities
2960370 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3505587 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
781551 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
656146 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
174555375 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167649028 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-141802321 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128040282 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
33535397 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40265684 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36495767 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43771271 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
371591 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
350207 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
686159 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
630524 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
134075 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
142877 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
243518 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
237516 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
207330 usd
us-gaap Gross Profit
GrossProfit
442641 usd
us-gaap Gross Profit
GrossProfit
389889 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2351696 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2077973 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4775347 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5348750 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
909113 usd
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
567796 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1800184 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1142608 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
271022 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
159788 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
575489 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
274429 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7231093 usd
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7231093 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10525408 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2598227 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13939472 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6375898 usd
CY2022Q2 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
41047 usd
CY2021Q2 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
57033 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
83477 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
85292 usd
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2217 usd
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1829 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3206 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
236801 usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
95254 usd
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-30909 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
97162 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
64762 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10391324 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2573932 usd
us-gaap Net Income Loss
NetIncomeLoss
-13762039 usd
us-gaap Net Income Loss
NetIncomeLoss
-6462645 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10391324 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2573932 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13762039 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6462645 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68896506
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51581762
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67374250
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44089157
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68896506
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51581762
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67374250
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44089157
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40265684 usd
CY2022Q1 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
86885 usd
CY2022Q1 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
162122 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
36518 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3370715 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
37180494 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6507050 usd
CY2022Q2 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
149124 usd
CY2022Q2 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
50670 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
39383 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10391324 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
33535397 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2642681 usd
CY2021Q1 poai Stock Issued During Period Value Accrued Interest
StockIssuedDuringPeriodValueAccruedInterest
143573 usd
CY2021Q1 poai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
4495270 usd
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
514011 usd
CY2021Q1 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
-4048 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
565082 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3888713 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
35545087 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2021Q2 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
588590 usd
CY2021Q2 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
48802 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
33243 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2573932 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
53088086 usd
us-gaap Net Income Loss
NetIncomeLoss
-13762039 usd
us-gaap Net Income Loss
NetIncomeLoss
-6462645 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
649441 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
649126 usd
us-gaap Share Based Compensation
ShareBasedCompensation
75901 usd
us-gaap Share Based Compensation
ShareBasedCompensation
598325 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
212792 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
244830 usd
poai Gain Losses On Debt Revaluation
GainLossesOnDebtRevaluation
97162 usd
poai Gain Losses On Debt Revaluation
GainLossesOnDebtRevaluation
64762 usd
poai Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
usd
poai Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
52471 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7231093 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1700 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17799 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-60358 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
86931 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28291 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
157827 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-39852 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38104 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-430110 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-441328 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-198890 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29457 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
101317 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3684 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-88559 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6427806 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5526978 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
233572 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
610906 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
34844 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
22870 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-268416 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-633776 usd
poai Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts
6507050 usd
poai Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts
50515810 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4495270 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
-0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4162744 usd
poai Payments For Penalties
PaymentsForPenalties
-0 usd
poai Payments For Penalties
PaymentsForPenalties
1073470 usd
poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
236009 usd
poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
588590 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6743059 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50363456 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46837 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44202702 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28202615 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
678332 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28249452 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44881034 usd
poai Stock Issued During Period Value Exchange Agreement Accrued Interest
StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest
0 usd
poai Stock Issued During Period Value Exchange Agreement Accrued Interest
StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest
143573 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
514011 usd
us-gaap Interest Paid Net
InterestPaidNet
1439 usd
us-gaap Interest Paid Net
InterestPaidNet
694435 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28249452 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
530797 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
186951 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
530797 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Accounting Policies and Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and during the reporting period. Actual results could materially differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
336397 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
354196 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101612 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143322 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Credit Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <em style="font: inherit;">one</em> financial institution. The Company has <em style="font: inherit;">zero</em> credit risk for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
282268 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
193287 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
186043 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
183410 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6305 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10987 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
474616 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
387684 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4786057 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4579909 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2485730 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2068338 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2300327 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2511571 usd
CY2022Q2 us-gaap Depreciation
Depreciation
222473 usd
CY2021Q2 us-gaap Depreciation
Depreciation
244062 usd
us-gaap Depreciation
Depreciation
442551 usd
us-gaap Depreciation
Depreciation
482993 usd
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4268724 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
478087 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3790637 usd
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7958314 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1102648 usd
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2893548 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3962118 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
103366 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
83086 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
206890 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166133 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
207068 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
414139 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
414139 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
412056 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
394139 usd
CY2022Q2 poai Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
1949096 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3790637 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39383 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33243 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75901 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
598325 usd
CY2020Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
294382 usd
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
95671 usd
CY2021Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
198711 usd
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-30909 usd
CY2021Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
229620 usd
CY2021Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
129480 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1908 usd
CY2022Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
127572 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
95254 usd
CY2022Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
32318 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10391324 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2573932 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13762039 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6462645 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68896506
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51581762
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67374250
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44089157
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68896506
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51581762
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67374250
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44089157
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
371591 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
350207 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
686159 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
630524 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10391324 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2573932 usd
us-gaap Net Income Loss
NetIncomeLoss
-13762039 usd
us-gaap Net Income Loss
NetIncomeLoss
-6462645 usd
CY2022Q2 us-gaap Assets
Assets
36495767 usd
CY2021Q4 us-gaap Assets
Assets
43771271 usd

Files In Submission

Name View Source Status
0001171843-22-005622-index-headers.html Edgar Link pending
0001171843-22-005622-index.html Edgar Link pending
0001171843-22-005622.txt Edgar Link pending
0001171843-22-005622-xbrl.zip Edgar Link pending
ex_408599.htm Edgar Link pending
ex_408600.htm Edgar Link pending
ex_408601.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
poai-20220630.xsd Edgar Link pending
poai20220630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
poai-20220630_cal.xml Edgar Link unprocessable
poai-20220630_def.xml Edgar Link unprocessable
poai-20220630_lab.xml Edgar Link unprocessable
poai-20220630_pre.xml Edgar Link unprocessable
poai20220630_10q_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending